India and the EU have clinched a landmark Free Trade Agreement (FTA) — hailed by leaders as the ‘mother of all trade deals’ — ...

The former Gus's Fried Chicken in Collierville is set to be demolished to make way for a mixed-used project. Here's what's ...

The 22-year-old center is slated to make his return Thursday to a team still fighting to get in the playoff mix.

Where Winds Meet has a variety of boss fights that you can challenge daily to secure some new gear and various other rewards, ...

People shopping for furniture at Winnipeg’s largest mall will soon be able to quaff a coffee and partake in a pastry while ...

How convincing are claims that private credit can substitute for traditional fixed income in institutional portfolios, and ...

Armor is a fun way to customize how Jin looks in Ghost of Tsushima. Check out the best armor sets in the game - and how you ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

Recent technological advances have set the stage for a renewed focus on human-based solutions called new approach methodologies (NAMs) that can ...

Unifrance Boss Gilles Pélisson reflects on first mandate and lays out how animation and co-productions are driving the appeal ...

With Washington, Cobb and Davenport all on the same team, it immediately gives Auburn one of the deepest running back rooms in the SEC. Add new quarterback Byrum Brown, who rushed for 1,008 yards in ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...